“…It is well known that inflammatory mediators associated with OA include cytokines, chemokines, growth factors, Creatinine (mg/dl) Pretreatment 0.7 ± 0.1 0.7 ± 0.2 0.7 ± 0.1 p = 0.24 95% (CI) 0.7, 0.8 0.6, 0.7 0.6, 0.7 Postreatment 0.7 ± 0.2 0.7 ± 0.2 0.6 ± 0.2 p = 0.03 95% (CI) 0.7, 0.8 0.6, 0.8 0.6, 0.7 p value 0.45 0.67 0.04* adipokines, prostaglandins, leukotrienes, nitric oxide, and neuropeptides (Robinson et al, 2016). Historically, cyclooxygenase inhibitors (acetaminophen and NSAIDs) have been the most commonly used medications; however, due to the gastrointestinal, renal, cardiac, and haematological adverse effects of these medications, their long-term use is limited (Mora et al, 2018). Some mild side effects were observed during the treatment period, such as gastrointestinal symptoms (acidity, constipation, and oral ulcers), however, no significant differences were found.…”